MCAS Bundle

Description

#122 MCAS Part 1 Histamine Pharmacology and Therapies

1.5 CE Total | 1.5 of which is pharm

Although the spectrum of “mast-cell disorders” is much more far-reaching than histamine (or even mast cells), a thorough understanding of histamine biochemistry, physiology, and pharmacology is at the base of dealing with mast cell spectrum issues. In this “Part 1” of the MCAS series Dr. Anderson will outline the ways histamine is used in the human body, the ways it regulates and disrupts both allergic phenomenon and CNS activity, and how it is naturally released and broken down by the body. At each point the intersections of pharmacology and drug applications will be highlighted.

#100 MCAS Part 2- Mast Cell Activation to Mastocytosis Assessment and Therapy

1.5 CE Total | 1.0 of which is Pharm

Part 1 of this series went into histamine biology and management deeply. In this follow-up CE we will look more closely at the spectrum of mast cell disorders ranging from major pathologies in the mastocytosis family through all the functional mast cell activation syndromes. Causes, aggravations, therapies (natural and pharmacologic), and management will be addressed.

#109 MCAS Part 3

2.0 CE Total | 1.0 of which is Pharm

Mast cell diseases are seemingly on the rise. The diagnosis and recognition of them certainly are. In this third installment of the “MCAS-MCD” series, Dr. Anderson will bring together concepts begun in parts 1 & 2. The role of external triggers for mast cells, the “non-mast cell” cell types, confusing laboratory studies, and integrative therapies will all be discussed.